224 related articles for article (PubMed ID: 21036397)
1. Aplastic anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2010.
Malcovati L; de Latour RP; Risitano A
Leuk Res; 2011 Mar; 35(3):291-4. PubMed ID: 21036397
[TBL] [Abstract][Full Text] [Related]
2. Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2018.
Becktell K; Berlyne D; Pagliuca S; Pommert L; Prata PH; Margolis D; de Latour RP; Dufour C; Pierri F
Leuk Res; 2019 May; 80():19-25. PubMed ID: 30908982
[TBL] [Abstract][Full Text] [Related]
3. Aplastic Anemia & MDS International Foundation (AA&MDSIF): bone marrow failure disease scientific symposium 2012.
Savage SA; Pulsipher MA; Romano A; Berlyne D
Leuk Res; 2013 Jul; 37(7):848-51. PubMed ID: 23643149
[TBL] [Abstract][Full Text] [Related]
4. Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2014.
Visconte V; Lindsley RC; Berlyne D
Leuk Res; 2015 Jan; 39(1):110-3. PubMed ID: 25435026
[TBL] [Abstract][Full Text] [Related]
5. [Anemia with aplastic anemia, paroxysmal nocturnal hemoglobinuria and myelodysplastic syndromes].
Passweg JR
Ther Umsch; 2010 May; 67(5):251-5. PubMed ID: 20509122
[TBL] [Abstract][Full Text] [Related]
6. Aplastic Anemia and MDS International Foundation (AAMDSIF): Bone marrow failure disease scientific symposium 2016.
Zeidan AM; Battiwalla M; Berlyne D; Winkler T
Leuk Res; 2017 Feb; 53():8-12. PubMed ID: 27923195
[TBL] [Abstract][Full Text] [Related]
7. 11th Symposium on Aplastic Anemia and 9th Symposium on Myelodysplastic Syndromes in Children.
Manabe A; Kojima S
Pediatr Int; 2005 Oct; 47(5):572-4. PubMed ID: 16190967
[No Abstract] [Full Text] [Related]
8. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
Barrett J; Saunthararajah Y; Molldrem J
Semin Hematol; 2000 Jan; 37(1):15-29. PubMed ID: 10676908
[TBL] [Abstract][Full Text] [Related]
9. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
Konoplev S; Medeiros LJ; Lennon PA; Prajapati S; Kanungo A; Lin P
Cancer; 2007 Oct; 110(7):1520-6. PubMed ID: 17701956
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North American Pediatric Aplastic Anemia Consortium.
Nakano TA; Lau BW; Dickerson KE; Wlodarski M; Pollard J; Shimamura A; Hofmann I; Sasa G; Elghetany T; Cada M; Dror Y; Ding H; Allen SW; Hanna R; Campbell K; Olson TS
Pediatr Blood Cancer; 2020 Oct; 67(10):e28652. PubMed ID: 32779892
[TBL] [Abstract][Full Text] [Related]
11. Circulating S100A8 and S100A9 protein levels in plasma of patients with acquired aplastic anemia and myelodysplastic syndromes.
Giudice V; Wu Z; Kajigaya S; Fernandez Ibanez MDP; Rios O; Cheung F; Ito S; Young NS
Cytokine; 2019 Jan; 113():462-465. PubMed ID: 29958797
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of aplastic anemia and myelodysplastic syndrome.
Paquette RL
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):153-61. PubMed ID: 12380966
[TBL] [Abstract][Full Text] [Related]
13. Application of serum Raman spectroscopy in rapid and early discrimination of aplastic anemia and myelodysplastic syndrome.
Liang H; Kong X; Ren Y; Wang H; Liu E; Sun F; Zhu G; Zhang Q; Zhou Y
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Dec; 302():123008. PubMed ID: 37328404
[TBL] [Abstract][Full Text] [Related]
14. Consensus Conference on the Treatment of Aplastic Anemia.
Kojima S; Nakao S; Tomonaga M; Hows J; Marsh J; Gerard S; Bacigalupo A; Mizoguchi H
Int J Hematol; 2000 Jul; 72(1):118-23. PubMed ID: 10979223
[TBL] [Abstract][Full Text] [Related]
15. Comparison of T lymphocyte subsets in aplastic anemia and hypoplastic myelodysplastic syndromes.
Zhang HF; Huang ZD; Wu XR; Li Q; Yu ZF
Life Sci; 2017 Nov; 189():71-75. PubMed ID: 28935248
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and Therapy of aplastic anemia - update 2021].
Panse J
Dtsch Med Wochenschr; 2021 Apr; 146(7):451-454. PubMed ID: 33780990
[TBL] [Abstract][Full Text] [Related]
17. [Myelodysplastic syndrome with der (1;7) transformed from aplastic anemia 42 years after onset].
Kanemura N; Tsurumi H; Hara T; Yamada T; Moriwaki H
Rinsho Ketsueki; 2005 May; 46(5):372-4. PubMed ID: 16444972
[TBL] [Abstract][Full Text] [Related]
18. Observational Monitoring of Patients with Aplastic Anemia and Low/Intermediate-1 Risk of Myelodysplastic Syndromes Complicated with Iron Overload.
Du Y; Long Z; Chen M; Han B; Hou B; Feng F
Acta Haematol; 2017; 138(2):119-128. PubMed ID: 28866669
[TBL] [Abstract][Full Text] [Related]
19. Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia.
Iwasaki T; Murakami M; Sugisaki C; Sobue S; Ohashi H; Asano H; Suzuki M; Nakamura S; Ito M; Murate T
Pathol Int; 2008 Jun; 58(6):353-60. PubMed ID: 18477214
[TBL] [Abstract][Full Text] [Related]
20. The Myelodysplastic Syndromes (MDS) Foundation: a retrospective analysis of a nonprofit foundation.
Bennett JM; Hamblin TJ; Mufti GJ
Leuk Res; 2011 Mar; 35(3):283-5. PubMed ID: 20971510
[No Abstract] [Full Text] [Related]
[Next] [New Search]
